Related Experiment Videos
Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study
Christian Otte1, Stefan Wüst, Shoujun Zhao
1Department of Psychiatry, University Medical Center, 20246 Hamburg-Eppendorf, Germany. otte@uke.de
Insights
Glucocorticoid receptor (GR) gene haplotype 3 is linked to increased heart failure (HF) risk and systolic dysfunction in coronary heart disease (CHD) patients. Low-grade inflammation partially explains this association.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- A common glucocorticoid receptor (GR) gene haplotype is linked to coronary heart disease (CHD) susceptibility.
- The association between this GR haplotype and heart failure (HF) remains uninvestigated.
Purpose of the Study:
- To determine if GR haplotype 3 is associated with HF.
- To investigate if low-grade inflammation, measured by C-reactive protein, mediates this association.
Main Methods:
- Prospective cohort study involving 526 white outpatients with stable CHD.
- Genotyping for common GR gene polymorphisms and haplotype analysis.
- Assessment of echocardiographic evidence of ventricular dysfunction, self-reported HF, and HF hospitalizations.
Main Results:
- Participants with two copies of GR haplotype 3 showed increased likelihood of prevalent HF (HR 4.15) and HF hospitalization (HR 3.0) over 6 years.
- A trend towards increased systolic dysfunction was observed (HR 3.0).
- Associations were attenuated after adjusting for C-reactive protein levels, indicating partial mediation by inflammation.
Conclusions:
- GR gene haplotype 3 is associated with prevalent HF, systolic dysfunction, and subsequent HF hospitalizations in CHD patients.
- Low-grade inflammation partially mediates the link between GR haplotype 3 and HF.
Context:
A common haplotype of the glucocorticoid receptor (GR) gene has been associated with increased susceptibility to coronary heart disease (CHD). Whether this haplotype predisposes to heart failure (HF) is unknown.
Objective:
The objective of the study was to determine whether GR haplotype 3 is associated with HF and whether this association is explained by low-grade inflammation (C-reactive protein).
Design:
In a prospective cohort study, participants were genotyped for common GR gene polymorphisms (ER22/23EK, BclI C/G, N363S, 9beta A/G). Haplotype analyses were conducted.
Setting:
The study was conducted at one university medical center, two Veterans Affairs medical centers, and nine public health clinics.
Patients:
Patients included 526 white outpatients with stable CHD.
Main Outcome Measures:
Echocardiographic evidence of ventricular dysfunction, self-reported heart failure, and subsequent hospitalization for heart failure were measured.
Results:
After adjusting for age, sex, smoking, and body mass index, participants with two copies of haplotype 3 were more likely than those with 0 or 1 copy to report heart failure [hazard ratio (HR) 4.15, 95% confidence interval (CI) 1.5-11.3, P < 0.01], have systolic dysfunction (left ventricular ejection fraction <50%) (HR 3.0, 95% CI 0.9-9.9, P = 0.07), and be hospitalized for HF during a mean follow-up of 6 yr (HR 3.0, 95% CI 1.3-7.0, P = 0.01). These associations were attenuated after adjustment for higher C-reactive protein levels in patients with two copies of haplotype 3.
Conclusions:
We found that the GR gene haplotype 3 was associated with prevalent HF, systolic dysfunction, and subsequent HF hospitalization in patients with CHD. This association was partly mediated by low-grade inflammation.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies